Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development
9 July 2019
Our news
Bringing you the latest!
Corporate
9 July 2019
5 April 2019
11 March 2019
24 January 2019
7 December 2017
19 October 2017
CONTACT